Tezepelumab for chronic sinusitis with nasal polyps in Russia
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tracks how well tezepelumab works for people with chronic sinusitis and nasal polyps in real-world settings. It aims to see if this medication reduces symptoms and the need for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need a diagnosis of chronic sinusitis with nasal polyps for at least 1 year.
- You must have medical records from the past year showing steroid use or nasal polyp surgery.
- You should have significant nasal blockage and moderate to severe sinus symptoms based on specific scoring.
- You cannot be pregnant, breastfeeding, or have any condition that makes tezepelumab unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with chronic rhinosinusitis with nasal polyps (CRSwNP)—a condition causing blocked sinuses and nasal growths—who are starting a new biologic medication called tezepelumab. Researchers will track how symptoms and quality of life improve over time in everyday medical practice.
This trial tests a medication called tezepelumab to see if it can improve symptoms for people with chronic sinusitis and nasal polyps who also have severe asthma. It may help reduce inflammation and improve breathing and nasal symptoms.
This study is testing a medicine called tezepelumab to see how it affects the lining (barrier) of the airways in people with severe asthma, with or without nasal polyps. Tezepelumab is given as an injection and may help reduce inflammation and improve asthma control.
This trial tests an injectable drug called TQC2731 for people with chronic sinusitis and nasal polyps that haven't been controlled well enough by standard treatments like steroid sprays or surgery. The goal is to see if it helps reduce nasal congestion, improve sense of smell, and shrink polyps.
This trial tests a new injectable medicine (lebrikizumab) for people with chronic sinusitis and nasal polyps that steroid treatments haven't controlled. It aims to reduce polyp size and improve breathing, smell, and congestion.
This study collects information from people with chronic rhinosinusitis and nasal polyps in both nostrils. By tracking patients over time, researchers hope to learn more about the condition and how to improve care.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.